How to Source Metyrapone for Pharmaceutical Formulation
Metyrapone (Tablets, 250 mg) is classified under Women's Health. It is therapeutically aligned with reference brands such as Metopirone (USA/EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Metyrapone for formulation, R&D, or bulk manufacturing.
Product Overview:
Metyrapone is a cortisol synthesis inhibitor used primarily in diagnostic testing of adrenal function (the metyrapone stimulation test). It works by blocking the enzyme 11‑beta‑hydroxylase in the adrenal gland, reducing cortisol production and allowing clinicians to assess pituitary ACTH reserve. In certain clinical situations, it may also be used to manage endogenous Cushing’s syndrome by lowering cortisol levels. Careful monitoring of hormone levels is required, and side effects can include nausea, dizziness, fatigue, and elevated ACTH.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Metyrapone must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Metyrapone is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Conclusion
Sourcing Metyrapone is more than procurement—it’s a strategic partnership. With its tablets form and 250 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Metyrapone.
Frequently Asked Questions For Sourcing of Metyrapone
What is the typical lead time for Metyrapone?
Lead times range from 4–6 weeks depending on supplier and region.
Is Metyrapone available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Metyrapone require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Metyrapone?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Metyrapone?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Metyrapone?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Metyrapone suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Metyrapone be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.